Emergency anticoagulation treatment for cirrhosis patients with portal vein thrombosis and acute variceal bleeding

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 6, 2012, Pages 686-691

  Maruyama, Hitoshi ^a   Takahashi, Masanori ^a   Shimada, Taro ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

anticoagulation; band ligation; esophageal varices; portal vein thrombosis; ultrasound

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; PERFLUBUTANE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTICOAGULATION; ARGON PLASMA COAGULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; EMERGENCY CARE; ENDOSCOPY; ESOPHAGUS VARICES BLEEDING; FEMALE; HEMOSTASIS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LIVER CIRRHOSIS; MALE; MICROBUBBLE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCLEROTHERAPY; THROMBOSIS; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANTICOAGULANTS; CONTRAST MEDIA; EMERGENCIES; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FERRIC COMPOUNDS; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEMOSTATIC TECHNIQUES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; IRON; LIGATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OXIDES; PILOT PROJECTS; PORTAL VEIN; PROSPECTIVE STUDIES; THROMBOSIS; TREATMENT OUTCOME;

EID: 84860848563     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.674972     Document Type: Article

References (19)

1. Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 2000;32:865-71.
2. Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther 2009;30:881-94.
3. D'Amico G, de Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003;38:599-612.
4. Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med 2001;45:1683-8.
5. Thatipelli MR, McBane RD, Hodge DO, Wysokinski WE. Survival and recurrence in patients with splanchnic vein thrombosis. Clin Gastroenterol Hepatol 2010;8:200-5.
6. Senzolo M, Tibbals J, Cholongitas E, Triantos CK, Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 2006; 23:767-75.
7. Luca A, Mitraglia R, Caruso S, Milazzo M, Sapere C, Maruzzelli L, et al. Short-and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 2011;60: 846-52.
8. Han G, Qi X, He C, Yin Z, Wang J, Xia J, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol 2011;54:78-88.
9. Maruyama H, Ishibashi H, Takahashi M, Shimada T, Kamesaki H, Yokosuka O. The prediction of the therapeutic effects of anticoagulation for recent portal vein thrombosis: a novel approach with contrast-enhanced ultrasound. Abdom Imaging. 2011;Sep 9. [Epub ahead of print].
10. Englesbe MJ, Kubus J, Muhammad W, Sonnenday CJ, Welling T, Punch JD, et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl 2010;16:83-90.
11. Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, et al. Splanchnic vein thrombosis in candidates for liver transplantation: use fullness of screening and anticoagulation. Gut 2005;54:691-7.
12. Amitrano L, Guardascione MG, Brancaccio V, Margaglione M, Manquso F, Grandone E, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004;40:736-41.
13. Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009;51:682-9.
14. Amitrano L, Guardascione MA, Menchise A, Matino R, Scaglione M, Giovine S, et al. Safety and efficacy of anticoagulation therapy with low molecular weight hepatic for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol 2010;44:448-51.
15. de Franchis R; On behalf of the Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762-8.
16. Petrasch F, Grothaus J, Mossner J, Hoffmeister A. Differences in bleeding behavior after endoscopic band ligation: a retrospective analysis. BMC Gastroenterol 2010;15:10-15.
17. Vieira da Rocha EC, D'Amico EA, Caldwell SH, Flores da Rocha TR, Soares E Silva CS, Dos Santos Bomfim V, et al. A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation. Clinical Gastroenterol Hepatol 2009;7:988-93.
18. Bajaj JS, Franco J. Endoscopic band ligation of esophageal varices in patients on anticoagulation. J Clin Gastroenterol 2008;42:782-5.
19. Bauer J, Johnson S, Durham J, Ludkowski M, Trotter J, Bak T, et al. The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl 2006;12:1544-51.